[1]
S. K. Paul, A. Guendouzi, A. Guendouzi, and R. Haldar, “Computational drug repurposing: Posaconazole emerges as a potent NAMPT inhibitor, offering promise for precision cancer therapeutics”, Ind. J. Physiol. Allied Sci., vol. 77, no. 02, Jun. 2025.